NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $25.66 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.